跳至主要内容
临床试验/NL-OMON23413
NL-OMON23413招募中不适用

Identification of muscle-invasive bladder cancer patients who will not benefit from neoadjuvant chemotherapy using circulating tumor cells.

Erasmus MC0 个研究点目标入组 260 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
Erasmus MC
入组人数
260

研究概览

简要总结

/A

研究设计

研究类型
Observational

入排标准

入选标准

  • Histopathologically confirmed muscle-invasive urothelial carcinoma of the bladder.
  • - Clinical stage T2-T4a N0-N1 bladder cancer.

排除标准

  • - Muscle-invasive bladder cancer other than urothelial carcinoma (adenocarcinoma, squamous cell carcinoma, small cell carcinoma, neuro-endocrine tumor).
  • - History of other malignant disease with a tumor-free interval of less than 5 years.

研究者

发起方
Erasmus MC

相似试验